Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component

Journal of Neuro-Oncology

Volumn 91, Issue 1, 2009, Pages 33-38

  Takeuchi, Hiroaki ^a   Kubota, Toshihiko ^a   Kitai, Ryuhei ^a   Matsuda, Ken ^a   Hashimoto, Norichika ^a   Sato, Kazufumi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Chromosome 19q; Chromosome 1p; Malignant glioneuronal tumor; Oligodendroglioma

Indexed keywords

BETA TUBULIN; CARBOPLATIN; CHROMOGRANIN A; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NEUROFILAMENT PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; NIMUSTINE; SYNAPTOPHYSIN;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CYTOGENETICS; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GLIOMA; GLIONEURONAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PROGNOSIS;

ADULT; AGED; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; OLIGODENDROGLIOMA;

EID: 57049104777     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9690-6     Document Type: Article

References (32)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2001) Pathology and genetics of tumours of the nervous system. International Agency of Research on Cancer, Lyon
2. Brat DJ, Scheithauer BW, Eberhart CG, Burger PC (2001) Extraventricular neurocytomas: Pathologic features and clinical outcome. Am J Surg Pathol 25:1252-1260. doi: 10.1097/00000478-200110000-00005
3. Giangaspero F, Cenacchi G, Losi L, Cerasoli S, Bisceglia M, Burger PC (1997) Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. Am J Surg Pathol 21:206-212. doi: 10.1097/00000478-199702000-00011
4. Komori T, Scheithauer BW, Anthony DC et al (1998) Papillary glioneuronal tumor: A new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol 22:1171-1183. doi: 10.1097/00000478-199810000-00002
5. Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61:947-955
6. Takeuchi H, Kabuto M, Sato K, Kubota T (1998) PNET (primitive neuroectodermal tumors) in an elderly patient with long term survival. J Clin Neurosci 5:466-469. doi: 10.1016/S0967-5868(98)90293-4
7. Takeuchi H, Sato K, Kitai R, Kubota T (2000) Clinicopathologic features of mixed Glio-neuronal tumors in adult. Brain Pathol 10:586
8. Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H et al (2004) New variants of malignant glioneuronal tumors: A clinicopathological study of 40 cases. Neurosurgery 55:1377-1392. doi: 10.1227/ 01.NEU.0000143033.36582.40
9. Bello MJ, Leone PE, Vaquero J, de Campos JM, Kusak ME, Sarasa JL et al (1995) Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 64:207-210. doi: 10.1002/ijc.2910640311
10. Deimling A (1995) Shared allelic loss on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95
11. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J et al (1995) Shared allelic loss on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95
12. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM et al (1999) Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18:4144-4152. doi: 10.1038/sj.onc.1202759
13. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479. doi: 10.1093/jnci/90.19.1473
14. Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707-2714
15. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645
16. Ino Y, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Jhung S et al (2000) Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 92:983-990
17. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S et al (2001) Glioblastomas with an oligodendroglial component: A pathological and molecular study. J Neuropathol Exp Neurol 60:863-871
18. Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M et al (2001) Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol 101:311-320
19. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM et al (1994) Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosom Cancer 10:275-281. doi: 10.1002/ gcc.2870100409
20. Weith A, Martinsson T, Cziepluch C, Bruderlein S, Amler LC et al (1998) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer 1:156-166
21. Mrak RE, Yasargil MG, Mohapatra G, Earel J, Louis DN (2004) Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. Hum Pathol 35:1156-1159. doi: 10.1016/j.humpath.2004.05.005
22. Nakagawa Y, Perentes E, Rubinstein LJ (1986) Immunohistochemical characterization of oligodendrogliomas: An analysis of multiple markers. Acta Neuropathol 72:15-22. doi: 10.1007/BF00687942
23. Sung CC, Collins R, Li J, Pearl DK, Coons SW, Scheithauer BW et al (1996) Glycolipids and myelin proteins in human oligodendrogliomas. Glycoconj J 13:433-443. doi: 10.1007/BF00731476
24. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997) Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurooncol 34:37-59. doi: 10.1023/A:1005707203596
25. Kros JM, Van Eden CG, Stefanko SZ, Waayer-Van Batenburg M, van der Kwast TH (1990) Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 66:1204-1212. doi:10.1002/ 1097-0142(19900915)66:6<1204::AID-CNCR2820660621>3.0.CO;2-A
26. Perry A (2001) Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore. Adv Anat Pathol 8:183-199. doi: 10.1097/ 00125480-200107000-00001
27. Dehghani F, Schachenmayr W, Laun A, Korf HW (1998) Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: A study of 89 cases. Acta Neuropathol 95:493-504. doi: 10.1007/s004010050830
28. Wharton SB, Chan KK, Hamilton FA, Anderson JR (1998) Expression of neuronal markers in oligodendrogliomas: An immunohistochemical study. Neuropathol Appl Neurobiol 24:302-308. doi: 10.1046/ j.1365-2990.1998.00132.x
29. Preusser M, Laggner U, Haberler C, Heinzl H, Budka H, Hainfellner JA (2006) Comparative analysis of NeuN immunoreactivity in primary brain tumours: Conclusions for rational use in diagnostic histopathology. Histopathology 48:438-444. doi: 10.1111/j.1365-2559.2006.02359.x
30. Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T, Wiestler OD et al (1996) NeuN: A useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 44:1167-1171
31. Englund C, Alvord EC, Folkerth RD, Silbergeld D, Born DE, Small R et al (2005) NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas. Neuropathol Appl Neurobiol 31:429-438. doi: 10.1111/j.1365-2990.2005.00665.x
32. Sarnat HB, Nochlin D, Born DE (1998) Neuronal nuclear antigen (NeuN): A marker of neuronal maturation in early human fetal nervous system. Brain Dev 20:88-94. doi: 10.1016/S0387-7604(97)00111-3